Clinical Trials Browser

Interventional × Osteosarcoma × saracatinib × Clear all

NCT00752206 2020-01-18

A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung

Phase 2 Terminated

38 enrolled 10 charts

Recurrence, Osteosarcoma